Literature DB >> 18084889

Structural survey of the peroxiredoxins.

P Andrew Karplus1, Andrea Hall.   

Abstract

Peroxiredoxins (Prxs) are ubiquitous proteins that use an active site Cys residue to reduce hydroperoxides. Structural studies since the first Prx structure was determined in 1998 have produced 35 crystal structures of wild type and mutant Prxs with at least one representative structure from each of the five major evolutionary subfamilies of Prxs. These structures have yielded a great deal of knowledge about Prx structure and structure-function relations, revealing fascinating variations in quaternary structure and details of the fully-folded and locally-unfolded conformations that are involved in the catalytic cycle of all Prxs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18084889     DOI: 10.1007/978-1-4020-6051-9_3

Source DB:  PubMed          Journal:  Subcell Biochem        ISSN: 0306-0225


  29 in total

1.  Exploring the biochemical mechanisms of cytotoxic gold compounds: a proteomic study.

Authors:  Francesca Magherini; Alessandra Modesti; Luca Bini; Michele Puglia; Ida Landini; Stefania Nobili; Enrico Mini; Maria Agostina Cinellu; Chiara Gabbiani; Luigi Messori
Journal:  J Biol Inorg Chem       Date:  2010-01-29       Impact factor: 3.358

2.  Crystallization and preliminary crystallographic analysis of mouse peroxiredoxin II with significant pseudosymmetry.

Authors:  Ari Ora; Esko Oksanen; Tommi Kajander; Adrian Goldman; Sarah J Butcher
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-02-27

Review 3.  Cysteine-mediated redox signaling: chemistry, biology, and tools for discovery.

Authors:  Candice E Paulsen; Kate S Carroll
Journal:  Chem Rev       Date:  2013-03-20       Impact factor: 60.622

4.  Structural snapshots of yeast alkyl hydroperoxide reductase Ahp1 peroxiredoxin reveal a novel two-cysteine mechanism of electron transfer to eliminate reactive oxygen species.

Authors:  Fu-Ming Lian; Jiang Yu; Xiao-Xiao Ma; Xiao-Jie Yu; Yuxing Chen; Cong-Zhao Zhou
Journal:  J Biol Chem       Date:  2012-04-02       Impact factor: 5.157

Review 5.  Orchestrating redox signaling networks through regulatory cysteine switches.

Authors:  Candice E Paulsen; Kate S Carroll
Journal:  ACS Chem Biol       Date:  2010-01-15       Impact factor: 5.100

6.  Aromatic Residues at the Dimer-Dimer Interface in the Peroxiredoxin Tsa1 Facilitate Decamer Formation and Biological Function.

Authors:  Matthew A Loberg; Jennifer E Hurtig; Aaron H Graff; Kristin M Allan; John A Buchan; Matthew K Spencer; Joseph E Kelly; Jill E Clodfelter; Kevin A Morano; W Todd Lowther; James D West
Journal:  Chem Res Toxicol       Date:  2019-02-11       Impact factor: 3.739

7.  Discovery of fragment molecules that bind the human peroxiredoxin 5 active site.

Authors:  Sarah Barelier; Dominique Linard; Julien Pons; André Clippe; Bernard Knoops; Jean-Marc Lancelin; Isabelle Krimm
Journal:  PLoS One       Date:  2010-03-17       Impact factor: 3.240

8.  Novel protective mechanism against irreversible hyperoxidation of peroxiredoxin: Nalpha-terminal acetylation of human peroxiredoxin II.

Authors:  Jae Ho Seo; Jung Chae Lim; Duck-Yeon Lee; Kyung Seok Kim; Grzegorz Piszczek; Hyung Wook Nam; Yu Sam Kim; Taeho Ahn; Chul-Ho Yun; Kanghwa Kim; P Boon Chock; Ho Zoon Chae
Journal:  J Biol Chem       Date:  2009-03-13       Impact factor: 5.157

9.  The crystal structure of the C45S mutant of annelid Arenicola marina peroxiredoxin 6 supports its assignment to the mechanistically typical 2-Cys subfamily without any formation of toroid-shaped decamers.

Authors:  Aude Smeets; Eléonore Loumaye; André Clippe; Jean-François Rees; Bernard Knoops; Jean-Paul Declercq
Journal:  Protein Sci       Date:  2008-04       Impact factor: 6.725

10.  Structural basis for a distinct catalytic mechanism in Trypanosoma brucei tryparedoxin peroxidase.

Authors:  Johannes Melchers; Michael Diechtierow; Krisztina Fehér; Irmgard Sinning; Ivo Tews; R Luise Krauth-Siegel; Claudia Muhle-Goll
Journal:  J Biol Chem       Date:  2008-08-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.